Monthly Communication Report

Corporation:	AstraZeneca Canada Inc.
Associated registration:	957438-15042-66
Communication date:	2026-04-30
Posted date:	2026-05-15

Designated Public Office Holders who participated in the communication:	Janice Charette, Chief Trade Negotiator to the US Global Affairs Canada (GAC) Rodrigo Arancibia, Director General, Health Emergency Readiness Canada Innovation, Science and Economic Development Canada (ISED) Martin Moen, Associate Assistant Deputy Minister Global Affairs Canada (GAC)
List of Details Subject matter Detail Economic Development, Health, International Trade, Research and Development, Taxation and Finance Engage with Canadian government officials to discuss and provide input on Canada’s countermeasures and policies in response to foreign tariffs affecting the pharmaceutical industry, as well as free trade agreements as they relate to the biopharmaceutical industry Budget, Economic Development, Federal-Provincial Relations, Foreign Affairs, Government Procurement, Health, Industry, International Trade, Research and Development Policy measures to ensure security of drug supply in Canada and preserve Canada’s attractiveness for biopharmaceutical launches, including in response to foreign pricing regulations
Responsible Officer who filed this communication report:	Gaby Bourbara
As the most senior paid officer, the person named above is responsible for certifying the communication report for the corporation or organization (Registrant). This person may or may not have participated in the reported communication. The Lobbyists Registration Regulations do not require that the names of in-house lobbyists (i.e. employees of corporations or organizations) who actually participated in the communication be disclosed.